A Research Domain Criteria Approach to Gambling Disorder and Behavioral Addictions
Decision-Making, Response Inhibition, and the Role of Cannabidiol
Bibliographic Data
| ID | 15526439 |
|---|---|
| Authors | Stefano Pallanti (0000-0001-5828-4868, Albert Einstein College of Medicine, corresponding author), Anna Marras (0000-0002-3793-1509, Neuroscience Institute), Nikolaos Makris (0000-0002-5707-4073, Massachusetts General Hospital), Νikolaos Makris (0000-0001-8028-7811) |
| Year | 2021 |
| Volume | 12 |
| Pages | 634418-634418 |
| Publication date | 2021-09-17 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2021.634418 |
| PMID | 34603091 |
| OpenAlex | W3199048600 |
| Language | EN |
| Citations received | 5 |
| References cited | 73 |
Gambling Disorder (GD) has been recently re-classified in the DSM-5 under the "substance-related and addictive disorders," in light of its genetic, endophenotypic, and phenotypic resemblances to substance dependence. Diminished control is a core defining concept of psychoactive substance dependence or addiction and has given rise to the concept of "behavioral" addictions, which are syndromes analogous to substance addiction, but with a behavioral focus other than ingestion of a psychoactive substance. The main symptom clusters are represented by loss of control, craving/withdrawal, and neglect of other areas of life, whereas in a Research Domain Criteria (RDoC) perspective, GD patients exhibit deficits in the domain of "Positive valence systems," particularly in the "Approach motivation" and "Reward learning" constructs, as well as in the "Cognitive systems," primarily in the "Cognitive control" construct. In the Addictions Neuroclinical Assessment (ANA), three relevant domains for addictions emerge: "Incentive salience," "Negative Emotionality," and "Executive Function." The endocannabinoid system (ECS) may largely modulate these circuits, presenting a promising pharmaceutical avenue for treating addictions. Up to now, research on cannabidiol has shown some efficacy in Attention Deficit/Hyperactivity Disorder (ADHD), whereas in behavioral addictions its role has not been fully elucidated, as well as its precise action on RDoC domains. Herein, we review available evidence on RDoC domains affected in GD and behavioral addictions and summarize insights on the use of cannabidiol in those disorders and its potential mechanisms of action on reward, decisional, and sensorimotor processes
Addiction · Cannabidiol · Cannabis · Cognition · Craving · Incentive salience · Psychiatry · Research Domain Criteria · Cannabis and Cannabinoid Research · Clinical Psychology · Gambling Behavior and Treatments · Neuroscience · Neurotransmitter Receptor Influence on Behavior · Psychology
Problematic social media use in youths cause response inhibition impairment
Treatment of Behavioral Addictions and Substance Use Disorders
Non-Substance Addictive Behaviors Among People with Intellectual Disability
A Family Study of Executive Function in Gambling Disorder
The profile of vulnerable groups in the context of the growth of gambling in Kazakhstan
Delay or Probability Discounting in a Model of Impulsive Behavior
Drug Addiction and Its Underlying Neurobiological Basis
Comorbidity of DSM-IV Pathological Gambling and Other Psychiatric Disorders
The Endophenotype Concept in Psychiatry
Separate Neural Systems Value Immediate and Delayed Monetary Rewards
Dysfunction of the prefrontal cortex in addiction
Insensitivity to future consequences following damage to human prefrontal cortex
The Nimh Research Domain Criteria (RDoC) Project
Introduction to Behavioral Addictions
Response inhibition in the stop-signal paradigm
Unravelling the association between inhibitory control and loss of control over eating among adolescents
| Citations per year | 1.67 |
|---|---|
| Citation span | 2023 - 2026 (4) |
| Highly cited | No |